Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

AAM Calls for Time Estimates, Clarifications in Supply Chain Waiver Guidance

  • Post author:Sam
  • Post published:July 10, 2018
  • Post category:Drug Industry Daily

The Association for Accessible Medicines urged the FDA to clarify its draft guidance on Drug Supply Chain Security Act (DSCSA) waivers by adding an estimated timetable for review decisions. Source:…

Continue ReadingAAM Calls for Time Estimates, Clarifications in Supply Chain Waiver Guidance

EMA: Many UK Drugmakers Are Behind Schedule on Brexit Preparedness

  • Post author:Sam
  • Post published:July 10, 2018
  • Post category:Drug Industry Daily

The European Medicines Agency expressed “serious concerns” about drugmakers’ preparedness for the UK’s departure from the European Union in a report released Tuesday. Source: Drug Industry Daily

Continue ReadingEMA: Many UK Drugmakers Are Behind Schedule on Brexit Preparedness

FDA Updates Warnings for Fluoroquinolone Antibiotics

  • Post author:Sam
  • Post published:July 10, 2018
  • Post category:Drug Industry Daily

The FDA on Tuesday announced that it will strengthen current warnings in the prescribing information for fluoroquinolone antibiotics regarding potential mental health side effects and blood sugar disturbances. Source: Drug…

Continue ReadingFDA Updates Warnings for Fluoroquinolone Antibiotics

Several Animal Studies Needed for Smallpox Drug Testing, FDA Says

  • Post author:Sam
  • Post published:July 10, 2018
  • Post category:Drug Industry Daily

Sponsors should rely on “several” animal studies to test the efficacy and safety of any smallpox treatments, the FDA says in a new draft guidance issued Tuesday. Source: Drug Industry…

Continue ReadingSeveral Animal Studies Needed for Smallpox Drug Testing, FDA Says

Chinese API Manufacturer Cited for Quality Shortcomings

  • Post author:Sam
  • Post published:July 10, 2018
  • Post category:Drug Industry Daily

The FDA issued a warning letter to Zhuhai United Laboratories, an active pharmaceutical ingredient firm based in Zhuhai, China, taking the facility to task for failure to investigate out-of-specification results…

Continue ReadingChinese API Manufacturer Cited for Quality Shortcomings

FDA Nixes United Therapeutics Petition on Tyvaso-Referencing Combination Products

  • Post author:Sam
  • Post published:July 9, 2018
  • Post category:Drug Industry Daily

The FDA denied a United Therapeutics petition urging the agency to reject ANDAs for combination products referencing the company’s hypertension drug Tyvaso (treprostinil). Source: Drug Industry Daily

Continue ReadingFDA Nixes United Therapeutics Petition on Tyvaso-Referencing Combination Products

Tennessee Lawsuit: Purdue Ignored Provider Misconduct, Red Flags

  • Post author:Sam
  • Post published:July 9, 2018
  • Post category:Drug Industry Daily

A newly-unsealed lawsuit by the state of Tennessee alleges Purdue violated a 2007 settlement with the state and continued to use providers with histories of misconduct to provide its products.…

Continue ReadingTennessee Lawsuit: Purdue Ignored Provider Misconduct, Red Flags

FDA to Team Up With Medical Community on Opioid Guidelines, Gottlieb Says

  • Post author:Sam
  • Post published:July 9, 2018
  • Post category:Drug Industry Daily

FDA officials will work with medical societies to come up with opioid-prescribing guidelines that regulators hope will strike a balance between the needs of chronic pain suffering and the need…

Continue ReadingFDA to Team Up With Medical Community on Opioid Guidelines, Gottlieb Says

Trump Blasts Pfizer for Raising Drug Prices

  • Post author:Sam
  • Post published:July 9, 2018
  • Post category:Drug Industry Daily

President Trump on Monday blasted Pfizer and other drug companies for hiking drug prices “for no reason.” Source: Drug Industry Daily

Continue ReadingTrump Blasts Pfizer for Raising Drug Prices

California OTC Drugmaker Flagged for Numerous Violations

  • Post author:Sam
  • Post published:July 6, 2018
  • Post category:Drug Industry Daily

The FDA hit Product Packaging West, an OTC drug manufacturer in Hollywood, California, with a Form 483 after an inspection revealed deficiencies with its purified water system, cleaning procedures and…

Continue ReadingCalifornia OTC Drugmaker Flagged for Numerous Violations
  • Go to the previous page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.